Recombinant Antibody Technology (United Kingdom)
- Research works
- 101 ▼ 63% vs 2013–17
- Citations
- 6.6k 65.9 per fractional work
- Top-10% rate
- 19.1% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: Recombinant Antibody Technology (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 6.8×. Every wedge is a field page.
Which keywords describe research at Recombinant Antibody Technology (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer, Biopharmaceuticals and Recombinant Proteins.
- Vaccine Antigens
- Ecology
- CAR T Cells
- Virus
- Microbiome
- Therapy
- Cancer Immunotherapy
- High-Throughput Analysis
- Cell Signaling
- CD4+CD25+
- Mammalian Cells
- Monoclonal Antibody
- Autoimmunity
- Stability
- Protein Aggregation
- Immune System
- Recombinant Proteins
- Cancer
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Biopharmaceuticals
- Glycans
- Immunogenicity
- Chromatography
- Inflammation
- Biopharmaceutical Production
- TGF-ß
- Recombinant Protein
- Foxp3
- Drug Discovery
- Protein Microarrays
- Targeted Therapy
- Signal Transduction
- Tumor Regression
- Bacteriophage
- Chimeric Antigen Receptor
- Plant Molecular Farming
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation29▲ 130×3 topics
- Monoclonal Antibodies26▲ 179×3 topics
- Therapeutic Antibodies25▲ 195×2 topics
- Antibody Engineering19▲ 190×1 topic
- Fc Receptors19▲ 190×1 topic
- Cancer10▲ 6.8×13 topics
- Biopharmaceuticals8▲ 122×3 topics
- Recombinant Proteins8▲ 144×2 topics
- Glycans7▲ 88×1 topic
- Immune System7▲ 22×1 topic
- Immunogenicity7▲ 132×2 topics
- Protein Aggregation6▲ 79×2 topics
- Chromatography6▲ 211×1 topic
- Stability6▲ 32×1 topic
- Inflammation4▲ 1.83×23 topics
- Autoimmunity3▲ 16×3 topics
- Biopharmaceutical Production3▲ 40×2 topics
- Monoclonal Antibody3▲ 46×2 topics
- TGF-ß3▲ 16×3 topics
- Mammalian Cells3▲ 68×1 topic
- Recombinant Protein3▲ 68×1 topic
- CD4+CD25+3▲ 35×1 topic
- Foxp33▲ 35×1 topic
- Cell Signaling2▲ 7.2×6 topics
- Drug Discovery2▲ 6.0×4 topics
- High-Throughput Analysis2▲ 52×1 topic
- Protein Microarrays2▲ 120×1 topic
- Cancer Immunotherapy2▲ 16×2 topics
- Targeted Therapy2▲ 9.7×3 topics
- Therapy2▲ 8.9×3 topics
- Signal Transduction2▲ 7.3×2 topics
- Microbiome2▲ 12×2 topics
- Tumor Regression2▲ 20×2 topics
- Virus2▲ 14×2 topics
- Bacteriophage2▲ 24×1 topic
- CAR T Cells2▲ 37×1 topic
- Chimeric Antigen Receptor2▲ 37×1 topic
- Ecology2▲ 7.7×1 topic
- Plant Molecular Farming2▲ 64×1 topic
- Vaccine Antigens2▲ 64×1 topic
Which research topics does Recombinant Antibody Technology (United Kingdom) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Molecular Biology Techniques and Applications, Pediatric Urology and Nephrology Studies and Salivary Gland Tumors Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 0 works
- 2 Molecular Biology Techniques and Applications Molecular Biology 0 works
- 3 Pediatric Urology and Nephrology Studies Pediatrics, Perinatology and Child Health 0 works
- 4 Salivary Gland Tumors Diagnosis and Treatment Surgery 0 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 6 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
- 7 Renal and Vascular Pathologies Pulmonary and Respiratory Medicine 0 works
- 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 9 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 0 works
- 10 Head and Neck Surgical Oncology Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Recombinant Antibody Technology (United Kingdom)'s research output changed?
Output in 2018–2022 was 63% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- University of Cambridge
- Addenbrooke's Hospital
- MRC Laboratory of Molecular Biology
- Anglia Ruskin University
- AstraZeneca (United Kingdom)
- Microsoft Research (United Kingdom)
- British Antarctic Survey
- Cambridge University Hospitals NHS Foundation Trust
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.